title: Comparison of the behavioural effects of an adenosine A1/A2-receptor antagonist, CGS 15943A, and an A1-selective antagonist, DPCPX.
abstract: CGS 15943A is the first reported nonxanthine adenosine antagonist and it shows high affinity towards A1 and A2 receptors. The present data show that CGS 15943A increased in a dose-dependent manner locomotor activity of mice confronted with a free exploratory test without markedly modifying rears or, at low or medium doses, novelty seeking responses. In the light/dark choice procedure, which is especially appropriate for revealing anxiolytic and anxiogenic drug-effects, CGS 15943A decreased the time spent by mice in the lit box and increased the number of transitions. By contrast, the highly selective adenosine A1 receptor, DPCPX, did not significantly modify the behavior of mice except at high doses, which decreased it in the free exploratory test. It is suggested that the present findings confirm the hypothesis that the behavioral effects of adenosine antagonists are linked to their actions at adenosine A2 receptors.
authors.affiliation: Laboratoire de Psychophysiologie, Strasbourg, France.
authors.forename: G
authors.initials: G
authors.lastname: Griebel
authors.forename: M
authors.initials: M
authors.lastname: Saffroy-Spittler
authors.forename: R
authors.initials: R
authors.lastname: Misslin
authors.forename: D
authors.initials: D
authors.lastname: Remmy
authors.forename: E
authors.initials: E
authors.lastname: Vogel
authors.forename: J J
authors.initials: JJ
authors.lastname: Bourguignon
mesh_terms: D000241:Adenosine / Q000037:antagonists & inhibitors*; D000818:Animals; D001522:Behavior, Animal / Q000187:drug effects*; D004305:Dose-Response Relationship, Drug; D005106:Exploratory Behavior / Q000187:drug effects; D008297:Male; D051379:Mice; D009043:Motor Activity / Q000187:drug effects; D058914:Purinergic Antagonists; D011799:Quinazolines / Q000494:pharmacology*; D014230:Triazoles / Q000494:pharmacology*; D014970:Xanthines / Q000494:pharmacology
chemical_list: D058914:Purinergic Antagonists; D011799:Quinazolines; D014230:Triazoles; D014970:Xanthines; C051360:1,3-dipropyl-8-cyclopentylxanthine; D000241:Adenosine; C052410:9-chloro-2-(2-furyl)-(1,2,4)triazolo(1,5-c)quinazolin-5-imine